We outline the market outlook for real-world data in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
What is real-world data?
Real-world data (RWD) platforms offer alternative datasets that can supplement drug development, clinical trial execution, and clinical decision-making. RWD platform providers collect data from a variety of sources, such as patient registries, electronic health records, insurance databases, social media, and patient research networks. Some products are offered as software subscriptions, while others are offered as data licensing agreements.
Features & capabilities
RWD platforms provide pharma and clinical research organization (CRO) leaders with several capabilities, including:
- Real-world evidence system with near real-time data to assess treatment
- Advanced data-driven clinical decision making
- Patient-centric digital solutions
- Customized strategies for intervention
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.
